I. Dewaardsiebinga et al., HLA EXPRESSION AND TUMOR-INFILTRATING IMMUNE CELLS IN UVEAL MELANOMA, Graefe's archive for clinical and experimental ophthalmology, 234(1), 1996, pp. 34-42
Background: In uveal melano ma, both the amount of tumor-infiltrating
cells and the level of expression of HLA antigens are quite variable.
We hypothesized that low levels of HLA expression lead to a lack of an
tigen presentation, which might prevent proper immunologic recognition
of the tumor. This lack of recognition might subsequently lead to low
levels of tumor-infiltrating cells. Methods: To test this hypothesis,
we determined the type and number of tumor-infiltrating cells in tumo
r sections from 24 uveal melanomas. We applied monoclonal antibodies d
irected against different types of immune cells and compared the resul
ts with the expression of HLA class I and class II antigens on the tur
ner cells. Results: Infiltrating immune cells were observed in all uve
al melanomas (although in small amounts), with a predominance of T lym
phocytes. Significant positive correlation:, were observed between the
number of CD3+ cells (T lymphocytes) and monomorphic HLA class I expr
ession, allele-specific HLA-A2 and Bw4 expression, and HLA class II ex
pression. Furthermore, the number of CD4+ cells (T helper cells, monoc
ytes/macrophages) and of CD11b+ cells (monocytes/macrophages) was sign
ificantly correlated with the level of monomorphic HLA class I express
ion. Conclusion: These data support our hypothesis that low levels of
HLA expression (and therefore a lack of presentation of tumor-specific
antigens) may lead to a low level of tumor infiltrate.